The NICE five fundamentals of #COPD care bmj.com/content/366/bm… NICE ERS #ERSCongress #erscongress2020

Comparing bronchial thermoplasty with biologicals for severe asthma: S... sciencedirect.com/science/articl…

Obesity associates with increased all-cause and cardiovascular mortali... sciencedirect.com/science/articl…

Real-world effectiveness of benralizumab in US subspecialist-treated a... sciencedirect.com/science/articl…

Mild asthma: Lessons learned and remaining questions sciencedirect.com/science/articl…

Approach to non-type 2 asthma sciencedirect.com/science/articl…

EUFOREA pocket guide on the diagnosis and management of asthma: An edu... sciencedirect.com/science/articl…

Congratulations Dr Steven Nathan on receiving the CHEST College Medalist Award to be awarded at #CHEST2023 in Honolulu

Patients with pulmonary hypertension due to chronic obstructive pulmonary disease (PH-COPD) had increased rates of severe exacerbations, hospitalizations, and costs compared with patients with COPD without PH. Study in Respiratory Medicine Journal. #pulmtwitter brnw.ch/21wDFN6

Effectiveness of omalizumab across different dosing regimens in patien... sciencedirect.com/science/articl… BCM PCCSM section

Identification of Sleep Phenotypes in COPD Using Machine Learning-Base... sciencedirect.com/science/articl…

Important stance against #vaping #ecigarette use ERS uniting our call American Thoracic Society (ATS) for better respiratory health

🔴 J1 [#ERSCongress]: are we ready for precision medicine? Athénaïs Boucly Hôpital Bicêtre AP-HP Réel intérêt à phénotyper les patients atteints d’#HTP ➡️ indentifier les facteurs théranostiques, proposer une prise en charge personnalisée. 📣 The right treatment for the right patient

Love to SEE the next generation of #ILDDocs EMERGING at #ERS2024 - congratiulatons for new job Dr. Alkhatib! #CureILD #ERSCongress #FutureIsBright @Ala_LK!!

Middle-aged adults who have smoked less than the current ‘critical threshold’ of 10-pack-years still have increased risk for chronic obstructive pulmonary disease (COPD), severe exacerbations, and early death. erj.ersjournals.com/content/early/… #ERSCongress

The 2024 GOLD International COPD Conference is an essential event for anyone treating COPD. Learn from top researchers about the latest studies and bring valuable insights back to your patients. Seats are limited—secure yours today! #GOLDCOPD2024 bit.ly/4bNNAUV

Treating eosinophilic exacerbations of #asthma and #COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial Read open access here: thelancet.com/journals/lanre… Mona Bafadhel British Thoracic Society (BTS) Sanjay Ramakrishnan King's Faculty of Life Sciences & Medicine

Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS) - Respiratory Medicine resmedjournal.com/article/S0954-…

Promoting Prevention and Targeting Remission of Asthma A EUFOREA Conse... sciencedirect.com/science/articl… BCM PCCSM section CHEST Airways Disorders Network

Comparative effectiveness of inhaled fluticasone propionate/salmeterol... sciencedirect.com/science/articl…